Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bacillus coagulans for postoperative intestinal function recovery after laparoscopy
ChiCTR2400079659Phase 4Not yet recruiting
- Sponsor
- Shanxi Bethune Hospital,Shanxi Academy of Medical Sciences,Tongji Shanxi Hospital,Third Hospital of Shanxi Medical University
- Start
- Jan 2024
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of bacillus coagulans in postoperative ileus (POI) (3 arms), sponsored by Shanxi Bethune Hospital,Shanxi Academy of Medical Sciences,Tongji Shanxi Hospital,Third Hospital of Shanxi Medical University. Primary endpoint: First postoperative exhaust time. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
bacillus coagulans
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on ChiCTR2400079659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400079659.